Personal information

Germany

Activities

Employment (4)

Boehringer Ingelheim Pharma GmbH & Co KG Biberach: Biberach, Baden-Württemberg, DE

2023-01-01 to present | Head of Application and Infrastructure (Translational Medicine & Clinical Pharmacology)
Employment
Source: Self-asserted source
Dr. Kai Bernd Stadermann

Boehringer Ingelheim Pharma GmbH & Co KG Biberach: Biberach, Baden-Württemberg, DE

2022-07-01 to 2022-12-31 | Principal Scientist - Clinical Bioinformatics (Translational Medicine & Clinical Pharmacology)
Employment
Source: Self-asserted source
Dr. Kai Bernd Stadermann

Boehringer Ingelheim Pharma GmbH & Co. KG: Biberach, Baden-Württemberg, DE

2019-01-01 to 2022-06-30 | Senior Scientist - Clinical Bioinformatics (Translational Medicine & Clinical Pharmacology)
Employment
Source: Self-asserted source
Dr. Kai Bernd Stadermann

Evonik Nutrition & Care GmbH: Halle (Westf.), Nordrhein-Westfalen, DE

2016-10-01 to 2018-12-31 | Bioinformatics Scientist
Employment
Source: Self-asserted source
Dr. Kai Bernd Stadermann

Education and qualifications (3)

Bielefeld University: Bielefeld, Nordrhein-Westfalen, DE

2013 to 2016-12 | Dr. rer. nat. (Faculty of Biology)
Education
Source: Self-asserted source
Dr. Kai Bernd Stadermann

Bielefeld University: Bielefeld, Nordrhein-Westfalen, DE

2010 to 2013-02 | Master of Science, Bioinformatics and Genome Research (Faculty of Technology)
Education
Source: Self-asserted source
Dr. Kai Bernd Stadermann

Bielefeld University: Bielefeld, Nordrhein-Westfalen, DE

2007 to 2010-11 | Bachelor of Science, Bioinformatics and Genome Research (Faculty of Technology)
Education
Source: Self-asserted source
Dr. Kai Bernd Stadermann

Works (9)

Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet

Biomedicine & Pharmacotherapy
2022-02 | Journal article
Part of ISSN: 0753-3322
Source: Self-asserted source
Dr. Kai Bernd Stadermann

A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway.

Molecular cancer therapeutics
2021-09-04 | Journal article
Source: Self-asserted source
Dr. Kai Bernd Stadermann

A chromosome-level sequence assembly reveals the structure of the Arabidopsis thaliana Nd-1 genome and its gene set.

PloS one
2019-05 | Journal article
Contributors: Pucker B; Holtgräwe D; Stadermann KB; Frey K; Huettel B; Reinhardt R; Weisshaar B
Source: Self-asserted source
Dr. Kai Bernd Stadermann via Europe PubMed Central

First complete genome sequence of Bacillus glycinifermentans B-27.

2017-04 | Journal article
Contributors: Stadermann KB; Blom J; Borgmeier C; Sciberras N; Herbold S; Kipker M; Meurer G; Molck S; Petri D; Pelzer S et al.
Source: Self-asserted source
Dr. Kai Bernd Stadermann via Europe PubMed Central

Chloroplast Genome Sequence of Arabidopsis thaliana Accession Landsberg erecta, Assembled from Single-Molecule, Real-Time Sequencing Data.

2016 | Journal article
Contributors: Stadermann KB; Holtgräwe D; Weisshaar B
Source: Self-asserted source
Dr. Kai Bernd Stadermann via Europe PubMed Central

ReadXplorer 2 - detailed read mapping analysis and visualization from one single source.

2016-08 | Journal article
Contributors: Hilker R; Bernd Stadermann K; Schwengers O; Anisiforov E; Jaenicke S; Weisshaar B; Zimmermann T; Goesmann A
Source: Self-asserted source
Dr. Kai Bernd Stadermann via Europe PubMed Central

Sugar Beet BeetMap-3, and Steps to Improve the Genome Assembly and Genome Sequence Annotation (W875)

2016-01-09 | Conference abstract
Source: Self-asserted source
Dr. Kai Bernd Stadermann

SMRT sequencing only de novo assembly of the sugar beet (Beta vulgaris) chloroplast genome.

2015 | Journal article
Contributors: Stadermann KB; Weisshaar B; Holtgräwe D
Source: Self-asserted source
Dr. Kai Bernd Stadermann via Europe PubMed Central

ReadXplorer--visualization and analysis of mapped sequences.

2014-08 | Journal article
Contributors: Hilker R; Stadermann KB; Doppmeier D; Kalinowski J; Stoye J; Straube J; Winnebald J; Goesmann A
Source: Self-asserted source
Dr. Kai Bernd Stadermann via Europe PubMed Central